Alexa, What is Eliquis and Xarelto?

A Study of Evacetrapib in High-Risk Vascular Disease

NCT01687998 ·Status: TERMINATED ·Phase: PHASE3

Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)

NCT00687076 ·Status: COMPLETED ·Phase: PHASE4

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

NCT07318610 ·Status: RECRUITING ·Phase: PHASE3

A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack

NCT07301034 ·Status: RECRUITING ·Phase: PHASE3

A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities

NCT01715818 ·Status: COMPLETED ·Phase: PHASE3

The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease

NCT05009862 ·Status: COMPLETED ·Phase: PHASE4

The ASPECT Study - Asian Paclitaxel-Eluting Stent Clinical Trial

NCT00196079 ·Status: COMPLETED ·Phase: NA

Relative Bioavailability of Single Doses of Dabigatran Etexilate When Administered Alone or in Combination With a Single Dose of Ketoconazole or in Combination With q.d. Ketoconazole at Steady State in Healthy Male and Female Volunteers

NCT02170675 ·Status: COMPLETED ·Phase: PHASE1

REvascularization RateS and Clinical OUtcomes With DABRA Laser. A Long-Term 2-year Study

NCT04010045 ·Status: TERMINATED

The Alirocumab for Stopping Atherosclerosis Progression in Saphenous Vein Grafts (ASAP-SVG) Pilot Trial

NCT03542110 ·Status: TERMINATED ·Phase: PHASE4

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AMG 890 in Subjects With Elevated Plasma Lipoprotein(a)

NCT03626662 ·Status: COMPLETED ·Phase: PHASE1

Drug Impregnated Bioabsorbable Stent in Asian Population Extremity Arterial Revascularization (DISAPEAR Study)

NCT02043795 ·Status: COMPLETED ·Phase: NA

Pharmacodynamic Effects of Low-dose Rivaroxaban With Antiplatelet Therapies

NCT03718429 ·Status: COMPLETED ·Phase: PHASE4

Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab

NCT02992301 ·Status: UNKNOWN ·Phase: PHASE4

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

NCT04774159 ·Status: RECRUITING ·Phase: PHASE3

Effects of Rivaroxaban on Vascular FMD in Patients With Stable Atherosclerotic Vascular Diseases

NCT06986369 ·Status: COMPLETED ·Phase: PHASE4

Influence of Rivaroxaban for Intermittent Claudication and Exercise Tolerance in Patients With Symptomatic PAD

NCT04305028 ·Status: UNKNOWN

Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients

NCT00751608 ·Status: WITHDRAWN ·Phase: PHASE2

A Drug Drug Interaction (DDI) Study of Selpercatinib and Dabigatran in Healthy Participants

NCT04782076 ·Status: COMPLETED ·Phase: PHASE1

L-Arginine in the Treatment of Peripheral Arterial Disease

NCT00284076 ·Status: COMPLETED ·Phase: NA

XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort

NCT01106534 ·Status: COMPLETED ·Phase: PHASE4

Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization

NCT03006770 ·Status: COMPLETED ·Phase: PHASE3

Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy

NCT06300450 ·Status: RECRUITING ·Phase: NA

Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication

NCT03194776 ·Status: COMPLETED ·Phase: PHASE2

ESCALATion of Medical Therapy Following Multimodality Plaque Evaluation in High-risk Chronic Coronary Syndromes

NCT06469528 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3